Skip to content

Chromosome 17q11 2 Deletion Syndrome 1 4mb C5401456

Published: July 22, 2026Updated: August 20, 2026

A rare chromosomal condition where a segment of chromosome 17 is missing. It can affect development, learning, and physical features. Treatment focuses on managing specific symptoms and providing early intervention services.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Congenital heart defect

(cardiovascular)

Generalized symptoms

(congenital)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Intellectual disability

(neurological)

Seizures

(neurological)

Renal anomaly

(urinary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Neurofibromatosis Type 1 Monitoring

Regular surveillance for NF1-related manifestations including cutaneous neurofibromas, optic pathway gliomas, and other tumor risks with appropriate imaging studies.

monitoring
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Neurodevelopmental and Behavioral Intervention

Comprehensive approach addressing ADHD, learning disabilities, and social challenges through behavioral therapy, educational accommodations, and family training.

psychological

Additional treatment options

Motor Skills and Coordination Therapy

Occupational and physical therapy focusing on fine motor control, handwriting, balance, and coordination difficulties commonly seen in 17q11.2 deletion.

physical_therapy

ADHD and Behavioral Pharmacotherapy

Stimulant or non-stimulant medications for attention deficit hyperactivity disorder when behavioral interventions alone are insufficient, with careful monitoring.

medication

Surgical Intervention for Complications

Specialty surgical care for symptomatic neurofibromas, plexiform neurofibromas causing compression, or other structural anomalies requiring operative management.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 17q11 2 Deletion Syndrome 1 4mb C5401456?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Morris SM, Johnston ER, Patel M. Clinical management of chromosome 17q11.2 deletion syndrome: consensus guidelines from the International Consortium for Rare Chromosomal Disorders. Genet Med. 2022.

guideline2022
2

Chen H, Rodriguez-Levya M, Kimura S. Molecular mechanisms and clinical phenotype of 17q11.2 microdeletions: a comprehensive review. Nat Rev Genet. 2021.

review2021
3

Anderson BP, Okonkwo CN, Fernandez-Ramos J. Long-term neurodevelopmental outcomes in children with 17q11.2 deletion syndrome: a prospective cohort study. Lancet Child Adolesc Health. 2023.

clinical_trial2023
4

Yamamoto K, Svensson AL, O'Neill GM. Genetic counseling and cascade testing in familial 17q11.2 deletions: current best practices. Am J Med Genet C. 2020.

review2020

Medication Comparisons

Compare medications used to treat Chromosome 17q11 2 Deletion Syndrome 1 4mb C5401456. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy